Kene Gallois


Kene Gallois has more than 10 years experience in the field of Biological Sciences. She graduated from the Fluminense Federal University (UFF) and has a Master's Degree from the Oswaldo Cruz Foundation (Fiocruz) in Cellular and Molecular Biology. She began her career working in research projects in Pathology, Immunology and Pharmacology and has been working with patents in the areas of Biotechnology, Pharmacy, Chemistry, Agriculture, Food and Cosmetics since 2009, providing specialized counseling to clients.

In 2015, she joined Daniel Legal & IP Strategy, where she coordinates the Life Sciences Division, providing several services related to the patent practice, such as drafting, filing and processing patent applications, performing searches, providing technical assistance in Court actions, preparing legal opinions and freedom-to-operate reports, analyzing the client’s portfolios and providing assistance on commercial strategies. She also attends meetings with clients and the Brazilian PTO examiners and trains newly-hired professionals, amongst other responsibilities.

Head of Life Sciences
Master’s Degree in Molecular and Cellular Biology from the Oswaldo Cruz Foundation (Fiocruz). Graduation in Biological Sciences from the Fluminense Federal University (UFF).
Área Atuação: 
Biotechnology Patents Pharma Chemistry
Afiliações, comissões e colegiados: 
Member of the Brazilian Intellectual Property Association – ABPI. Member of the Regional Council of Biology - CRBio-02.
É um sócio ?: 


BRPTO’s establishes guidelines for examining chemical patent applications

The Brazilian PTO published in January 2nd Rule 208/2017, which provides guidelines for the examination of patent applications related to the chemical field. As informed by our firm on 03/31/2017 (click here), a draft version of these guidelines was submitted to public consultation in March 2017. This new Rule is supplementary to the contents of BRPTO’s Rules 124/2013 and 169/2016 (Guidelines for the Examination of Patent Applications – Parts I and II, respectively).


Bridging the great divide

Since 2001, the grant of pharmaceutical-related patent applications in Brazil has come to depend on a prior approval analysis by the Brazilian National Health Surveillance Agency (ANVISA).

ANVISA and the Brazilian Patent and Trademark Office (INPI) initially agreed that pharma applications should be forwarded to ANVISA to receive prior approval after the INPI’s examination.


BRPTO and ANVISA's role regarding the examination of pharma patents application

On April 12, 2017, Brazilian PTO and ANVISA signed the Joint Ordinance # 1/2017, which establishes the procedures to be adopted concerning the analysis of pharmaceutical patent applications


BRPTO launched a public consultation inviting comments on chemical patents application

The Brazilian PTO published a draft guidelines for the examination of patent applications related to the chemical field.

Subscribe to RSS - Kene Gallois